Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ARGX, IONS, VRTX, ISRG, ALNY, and represent 22.53% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: EVH (+$28M), EXAS (+$20M), BMRN (+$20M), ABT (+$16M), INSP (+$15M), TNDM (+$13M), UNH (+$12M), SRPT (+$12M), IQV (+$8.9M), TERN (+$8.7M).
- Started 12 new stock positions in TERN, NAMS, BMY, ACLX, SMMT, TVTX, Summit Therapeutics, VCYT, SNY, BNTX. NRIX, DNLI.
- Reduced shares in these 10 stocks: BIO (-$37M), INSM (-$36M), ARGX (-$32M), CRL (-$31M), ALNY (-$31M), CNC (-$25M), CDNA (-$24M), Silk Road Medical Inc Common (-$23M), HCM (-$22M), ISRG (-$21M).
- Sold out of its positions in AAPL, ATRC, BCYC, CCCC, DVAX, ETNB, EXAI, FDMT, GRAL, NVRO. OM, Silk Road Medical Inc Common, TDOC, WST, ALKS.
- Bellevue Group was a net seller of stock by $-269M.
- Bellevue Group has $6.2B in assets under management (AUM), dropping by 0.30%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bellevue Group
Bellevue Group holds 163 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Argenx Se Sponsored Adr (ARGX) | 5.6 | $343M | -8% | 633k | 542.08 |
|
| Ionis Pharmaceuticals (IONS) | 5.1 | $315M | -4% | 7.9M | 40.06 |
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $266M | -3% | 571k | 465.08 |
|
| Intuitive Surgical Com New (ISRG) | 4.0 | $244M | -7% | 497k | 491.27 |
|
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $223M | -12% | 809k | 275.03 |
|
| Revolution Medicines (RVMD) | 3.6 | $221M | -3% | 4.9M | 45.35 |
|
| Neurocrine Biosciences (NBIX) | 3.5 | $215M | 1.9M | 115.22 |
|
|
| Boston Scientific Corporation (BSX) | 3.3 | $206M | -4% | 2.5M | 83.80 |
|
| Abbott Laboratories (ABT) | 3.2 | $199M | +8% | 1.7M | 114.01 |
|
| Stryker Corporation (SYK) | 3.1 | $190M | -3% | 527k | 361.26 |
|
| Intra Cellular Therapies (ITCI) | 2.9 | $182M | 2.5M | 73.17 |
|
|
| Agios Pharmaceuticals (AGIO) | 2.7 | $166M | -3% | 3.7M | 44.43 |
|
| Incyte Corporation (INCY) | 2.3 | $142M | 2.2M | 66.10 |
|
|
| UnitedHealth (UNH) | 2.1 | $132M | +9% | 226k | 584.68 |
|
| Moderna (MRNA) | 1.7 | $107M | +2% | 1.6M | 66.83 |
|
| Celldex Therapeutics Com New (CLDX) | 1.7 | $104M | +3% | 3.1M | 33.99 |
|
| Biohaven (BHVN) | 1.7 | $102M | 2.0M | 49.97 |
|
|
| EXACT Sciences Corporation (EXAS) | 1.6 | $99M | +25% | 1.4M | 68.12 |
|
| Caredx (CDNA) | 1.6 | $98M | -19% | 3.1M | 31.23 |
|
| Insulet Corporation (PODD) | 1.6 | $98M | -3% | 422k | 232.75 |
|
| Medtronic SHS (MDT) | 1.5 | $91M | 1.0M | 90.03 |
|
|
| Becton, Dickinson and (BDX) | 1.3 | $81M | -2% | 338k | 241.10 |
|
| Tandem Diabetes Care Com New (TNDM) | 1.3 | $79M | +19% | 1.9M | 42.41 |
|
| Evolent Health Cl A (EVH) | 1.2 | $76M | +59% | 2.7M | 28.28 |
|
| Edwards Lifesciences (EW) | 1.2 | $75M | -10% | 1.1M | 65.99 |
|
| Dex (DXCM) | 1.1 | $68M | -19% | 1.0M | 67.04 |
|
| Arvinas Ord (ARVN) | 1.0 | $59M | 2.4M | 24.63 |
|
|
| Penumbra (PEN) | 0.9 | $53M | -3% | 273k | 194.31 |
|
| Relay Therapeutics (RLAY) | 0.8 | $52M | +15% | 7.4M | 7.08 |
|
| Option Care Health Com New (OPCH) | 0.8 | $52M | +16% | 1.7M | 31.30 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.8 | $50M | +2% | 532k | 93.85 |
|
| Procept Biorobotics Corp (PRCT) | 0.8 | $49M | -8% | 613k | 80.12 |
|
| Essa Pharma Com New (EPIX) | 0.8 | $48M | 7.9M | 6.06 |
|
|
| Zimmer Holdings (ZBH) | 0.8 | $47M | -3% | 433k | 107.95 |
|
| Hca Holdings (HCA) | 0.8 | $47M | -6% | 115k | 406.43 |
|
| Anthem (ELV) | 0.8 | $47M | -12% | 89k | 520.00 |
|
| IDEXX Laboratories (IDXX) | 0.7 | $46M | -2% | 91k | 505.22 |
|
| Cooper Cos (COO) | 0.7 | $44M | 397k | 110.34 |
|
|
| Sarepta Therapeutics (SRPT) | 0.7 | $43M | +36% | 344k | 124.89 |
|
| Exelixis (EXEL) | 0.7 | $42M | -11% | 1.6M | 25.95 |
|
| Inspire Med Sys (INSP) | 0.7 | $41M | +56% | 195k | 211.05 |
|
| Cigna Corp (CI) | 0.7 | $41M | -3% | 118k | 346.44 |
|
| Eli Lilly & Co. (LLY) | 0.6 | $39M | -10% | 44k | 885.94 |
|
| ResMed (RMD) | 0.6 | $39M | +2% | 160k | 244.12 |
|
| Insmed Com Par $.01 (INSM) | 0.6 | $38M | -48% | 525k | 73.00 |
|
| Edgewise Therapeutics (EWTX) | 0.6 | $38M | 1.4M | 26.69 |
|
|
| Immunocore Hldgs Ads (IMCR) | 0.6 | $38M | +4% | 1.2M | 31.13 |
|
| Beam Therapeutics (BEAM) | 0.6 | $37M | +7% | 1.5M | 24.50 |
|
| Black Diamond Therapeutics (BDTX) | 0.6 | $37M | 8.5M | 4.35 |
|
|
| Align Technology (ALGN) | 0.6 | $37M | 144k | 254.32 |
|
|
| Castle Biosciences (CSTL) | 0.6 | $36M | +3% | 1.3M | 28.52 |
|
| Verona Pharma Sponsored Ads (VRNA) | 0.6 | $35M | +7% | 1.2M | 28.77 |
|
| Veeva Sys Cl A Com (VEEV) | 0.6 | $34M | -3% | 164k | 209.87 |
|
| Globus Med Cl A (GMED) | 0.5 | $34M | -5% | 470k | 71.54 |
|
| Wave Life Sciences SHS (WVE) | 0.5 | $34M | 4.1M | 8.20 |
|
|
| Thermo Fisher Scientific (TMO) | 0.5 | $33M | +25% | 54k | 618.57 |
|
| Axsome Therapeutics (AXSM) | 0.5 | $33M | -28% | 367k | 89.87 |
|
| Macrogenics (MGNX) | 0.5 | $33M | 9.9M | 3.29 |
|
|
| Sage Therapeutics (SAGE) | 0.5 | $32M | 4.5M | 7.22 |
|
|
| Iqvia Holdings (IQV) | 0.5 | $31M | +40% | 130k | 236.97 |
|
| Annexon (ANNX) | 0.5 | $31M | 5.2M | 5.92 |
|
|
| Danaher Corporation (DHR) | 0.5 | $29M | +25% | 106k | 278.02 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $29M | 610k | 46.98 |
|
|
| Regeneron Pharmaceuticals (REGN) | 0.5 | $28M | -17% | 27k | 1051.24 |
|
| Structure Therapeutics Sponsord Ads (GPCR) | 0.4 | $28M | +12% | 630k | 43.89 |
|
| Transmedics Group (TMDX) | 0.4 | $27M | -15% | 170k | 157.00 |
|
| Neogenomics Com New (NEO) | 0.4 | $24M | +34% | 1.6M | 14.75 |
|
| Molina Healthcare (MOH) | 0.4 | $23M | -11% | 68k | 344.56 |
|
| BioMarin Pharmaceutical (BMRN) | 0.4 | $23M | +533% | 331k | 70.29 |
|
| Steris Shs Usd (STE) | 0.4 | $22M | 91k | 242.54 |
|
|
| Hologic (HOLX) | 0.3 | $20M | 248k | 81.46 |
|
|
| Si-bone (SIBN) | 0.3 | $20M | +4% | 1.4M | 13.98 |
|
| Privia Health Group (PRVA) | 0.3 | $19M | 1.1M | 18.21 |
|
|
| McKesson Corporation (MCK) | 0.3 | $18M | -22% | 36k | 494.42 |
|
| Natera (NTRA) | 0.3 | $18M | -35% | 139k | 126.95 |
|
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $17M | 2.2M | 8.01 |
|
|
| Fate Therapeutics (FATE) | 0.3 | $17M | 4.8M | 3.50 |
|
|
| Esperion Therapeutics (ESPR) | 0.3 | $16M | 9.9M | 1.65 |
|
|
| AmerisourceBergen (COR) | 0.3 | $16M | -19% | 72k | 225.08 |
|
| Bio Rad Labs Cl A (BIO) | 0.3 | $15M | -70% | 46k | 334.58 |
|
| Astrana Health Com New (ASTH) | 0.2 | $15M | 254k | 57.94 |
|
|
| Charles River Laboratories (CRL) | 0.2 | $14M | -68% | 73k | 196.97 |
|
| Beigene Sponsored Adr (BGNE) | 0.2 | $13M | +129% | 59k | 224.51 |
|
| Generation Bio (GBIO) | 0.2 | $9.7M | 3.9M | 2.47 |
|
|
| Phreesia (PHR) | 0.2 | $9.6M | -4% | 422k | 22.79 |
|
| Humana (HUM) | 0.1 | $9.0M | 28k | 316.74 |
|
|
| Terns Pharmaceuticals (TERN) | 0.1 | $8.7M | NEW | 1.0M | 8.34 |
|
| Omnicell (OMCL) | 0.1 | $8.6M | -15% | 198k | 43.60 |
|
| Abbvie (ABBV) | 0.1 | $8.5M | 43k | 197.48 |
|
|
| Johnson & Johnson (JNJ) | 0.1 | $8.3M | +557% | 51k | 162.06 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $8.2M | -54% | 169k | 48.73 |
|
| Glaukos (GKOS) | 0.1 | $8.2M | +12% | 63k | 130.28 |
|
| Amgen (AMGN) | 0.1 | $8.1M | -14% | 25k | 322.21 |
|
| Centene Corporation (CNC) | 0.1 | $6.5M | -79% | 87k | 75.28 |
|
| 10x Genomics Cl A Com (TXG) | 0.1 | $6.4M | -8% | 282k | 22.58 |
|
| Illumina (ILMN) | 0.1 | $5.9M | +3% | 45k | 130.41 |
|
| Altimmune Com New (ALT) | 0.1 | $5.3M | +43% | 864k | 6.14 |
|
| Merck & Co (MRK) | 0.1 | $4.8M | -43% | 42k | 113.56 |
|
| Waystar Holding Corp (WAY) | 0.1 | $4.2M | 150k | 27.89 |
|
|
| Pfizer (PFE) | 0.1 | $4.1M | +59% | 141k | 28.94 |
|
| Gilead Sciences (GILD) | 0.1 | $3.9M | +18% | 46k | 83.84 |
|
| Cardinal Health (CAH) | 0.1 | $3.3M | -7% | 30k | 110.52 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.0 | $2.6M | -20% | 34k | 77.91 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 0.0 | $2.6M | -7% | 393k | 6.59 |
|
| Accolade (ACCD) | 0.0 | $2.5M | -23% | 641k | 3.85 |
|
| Bristol Myers Squibb (BMY) | 0.0 | $1.9M | NEW | 37k | 51.74 |
|
| Encompass Health Corp (EHC) | 0.0 | $1.9M | +38% | 19k | 96.64 |
|
| Molecular Templates Com New (MTEM) | 0.0 | $1.8M | 1.3M | 1.41 |
|
|
| Dr Reddys Labs Adr (RDY) | 0.0 | $1.6M | -11% | 21k | 79.45 |
|
| Summit Therapeutics (SMMT) | 0.0 | $1.4M | NEW | 64k | 21.90 |
|
| CVS Caremark Corporation (CVS) | 0.0 | $1.4M | 22k | 62.88 |
|
|
| Vaxcyte (PCVX) | 0.0 | $1.4M | -15% | 12k | 114.27 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $1.3M | -54% | 71k | 18.02 |
|
| Doximity Cl A (DOCS) | 0.0 | $1.3M | -59% | 29k | 43.57 |
|
| Certara Ord (CERT) | 0.0 | $1.1M | 96k | 11.71 |
|
|
| Biontech Se Sponsored Ads (BNTX) | 0.0 | $1.0M | NEW | 8.7k | 118.77 |
|
| Zoetis Cl A (ZTS) | 0.0 | $1.0M | +79% | 5.3k | 195.38 |
|
| Viking Therapeutics (VKTX) | 0.0 | $1.0M | +267% | 16k | 63.31 |
|
| Alphabet Cap Stk Cl C (GOOG) | 0.0 | $1.0M | 6.0k | 167.19 |
|
|
| Tenet Healthcare Corp Com New (THC) | 0.0 | $935k | +3% | 5.6k | 166.20 |
|
| Sanofi Sponsored Adr (SNY) | 0.0 | $871k | NEW | 15k | 57.63 |
|
| Krystal Biotech (KRYS) | 0.0 | $870k | +13% | 4.8k | 182.03 |
|
| Rhythm Pharmaceuticals (RYTM) | 0.0 | $823k | +20% | 16k | 52.39 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $636k | +21% | 76k | 8.32 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $578k | -34% | 11k | 52.80 |
|
| Protagonist Therapeutics (PTGX) | 0.0 | $556k | -18% | 12k | 45.00 |
|
| Apellis Pharmaceuticals (APLS) | 0.0 | $549k | -95% | 19k | 28.84 |
|
| Adma Biologics (ADMA) | 0.0 | $518k | -16% | 26k | 19.99 |
|
| Biogen Idec (BIIB) | 0.0 | $511k | -55% | 2.6k | 193.84 |
|
| Hutchmed China Sponsored Ads (HCM) | 0.0 | $469k | -97% | 24k | 19.53 |
|
| Denali Therapeutics (DNLI) | 0.0 | $457k | NEW | 16k | 29.13 |
|
| Viatris (VTRS) | 0.0 | $456k | +48% | 39k | 11.61 |
|
| Travere Therapeutics (TVTX) | 0.0 | $434k | NEW | 31k | 13.99 |
|
| Merus N V (MRUS) | 0.0 | $400k | -18% | 8.0k | 49.96 |
|
| Arcutis Biotherapeutics (ARQT) | 0.0 | $367k | +125% | 40k | 9.30 |
|
| Arcellx Common Stock (ACLX) | 0.0 | $334k | NEW | 4.0k | 83.51 |
|
| Xenon Pharmaceuticals (XENE) | 0.0 | $323k | -19% | 8.2k | 39.37 |
|
| Nike CL B (NKE) | 0.0 | $309k | 3.5k | 88.40 |
|
|
| Blueprint Medicines (BPMC) | 0.0 | $296k | -37% | 3.2k | 92.50 |
|
| Kura Oncology (KURA) | 0.0 | $266k | +36% | 14k | 19.54 |
|
| Bridgebio Pharma (BBIO) | 0.0 | $265k | -18% | 10k | 25.46 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $233k | 1.1k | 212.22 |
|
|
| Ideaya Biosciences (IDYA) | 0.0 | $228k | +26% | 7.2k | 31.68 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $222k | 4.0k | 55.55 |
|
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $222k | 4.4k | 50.42 |
|
|
| Summit Therapeutics Call Call Option | 0.0 | $219k | NEW | 10k | 21.90 |
|
| Baidu Spon Adr Rep A (BIDU) | 0.0 | $211k | 2.0k | 105.29 |
|
|
| Mineralys Therapeutics (MLYS) | 0.0 | $200k | -5% | 17k | 12.11 |
|
| Garmin SHS (GRMN) | 0.0 | $185k | 1.1k | 176.03 |
|
|
| Nurix Therapeutics (NRIX) | 0.0 | $180k | NEW | 8.0k | 22.47 |
|
| Rocket Pharmaceuticals (RCKT) | 0.0 | $172k | -52% | 9.3k | 18.47 |
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $151k | +27% | 42k | 3.63 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.0 | $128k | NEW | 7.7k | 16.60 |
|
| Veracyte (VCYT) | 0.0 | $123k | NEW | 3.6k | 34.04 |
|
| Agilent Technologies Inc C ommon (A) | 0.0 | $114k | +9% | 769.00 | 148.48 |
|
| Oracle Corporation (ORCL) | 0.0 | $106k | +9% | 624.00 | 170.40 |
|
| NVIDIA Corporation (NVDA) | 0.0 | $87k | +9% | 716.00 | 121.44 |
|
| Microsoft Corporation (MSFT) | 0.0 | $84k | +8% | 194.00 | 430.30 |
|
| Qualcomm (QCOM) | 0.0 | $73k | +9% | 427.00 | 170.05 |
|
| Mettler-Toledo International (MTD) | 0.0 | $62k | +2% | 41.00 | 1499.71 |
|
| Omniab (OABI) | 0.0 | $49k | 12k | 4.23 |
|
|
| Labcorp Holdings Com Shs (LH) | 0.0 | $46k | +8% | 206.00 | 223.48 |
|
| Tempus Ai Cl A (TEM) | 0.0 | $29k | -89% | 516.00 | 56.60 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2024 Q3 filed Nov. 14, 2024
- Bellevue Group 2024 Q2 filed Aug. 14, 2024
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021